लोड हो रहा है...
Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones
BACKGROUND: The ongoing global malaria eradication campaign requires development of potent, safe, and cost-effective drugs lacking cross-resistance with existing chemotherapies. One critical step in drug development is selecting a suitable clinical candidate from late leads. The process used to sele...
में बचाया:
| में प्रकाशित: | Malar J |
|---|---|
| मुख्य लेखकों: | , , , , , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
BioMed Central
2021
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7893776/ https://ncbi.nlm.nih.gov/pubmed/33608015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-021-03617-1 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|